FTCM
GNMK

First Trust Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

First Trust Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-564,758
Closed -$13.5M – 275
2021
Q1 		$13.5M Buy
+564,758
New +$10.5M 2.64% 8

First Trust Capital Management's GNMK Position: Q2 2021 in Review

First Trust Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 564,758 shares — an estimated $13.5M sold.

First Trust Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $13.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • First Trust Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • First Trust Capital Management sold 564,758 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $13.5M.
  • First Trust Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • First Trust Capital Management's GenMark Diagnostics, Inc position peaked at $13.5M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on First Trust Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.